Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

To investigate the involvement of K + efflux in apoptotic cell shrinkage, we monitored efflux of the K + congener, 86 Rb + , and cell volume during CD95-mediated apoptosis in Jurkat cells. An anti-CD95 antibody caused apoptosis associated with intracellular GSH depletion, a significant increase in 86 Rb + efflux, and a decrease in cell volume compared with control cells. Preincubating Jurkat cells with Val-Ala-Asp-chloromethylketone (VAD- cmk), an inhibitor of caspase proteases, prevented the observed 86 Rb + efflux and cell shrinkage induced by the anti- CD95 antibody. A wide range of inhibitors against most types of K + channels could not inhibit CD95-mediated efflux of 86 Rb + , however, the uptake of 86 Rb + by Jurkat cells was severely compromised when treated with anti-CD95 antibody. Uptake of 86 Rb + in Jurkat cells was sensitive to ouabain (a specific Na + /K + -ATPase inhibitor), demonstrating Na + /K + -ATPase dependent K + uptake. Ouabain induced significant 86 Rb + efflux in untreated cells, as well as it seemed to compete with 86 Rb + efflux induced by the anti-CD95 antibody, supporting a role for Na + /K + -ATPase in the CD95-mediated 86 Rb + efflux. Ouabain treatment of Jurkat cells did not cause a reduction in cell volume, although together with the anti-CD95 antibody, ouabain potentiated CD95-mediated cell shrinkage. This suggests that the observed inhibition of Na + /K + -ATPase during apoptosis may also facilitate apoptotic cell shrinkage.

Original publication

DOI

10.1023/A:1009684713784

Type

Journal article

Journal

Apoptosis

Publication Date

04/07/2000

Volume

5

Pages

153 - 163